# Fisetin in Mild Alzheimer's Disease

> **NCT07279714** · PHASE2 · RECRUITING · sponsor: **Sunnybrook Health Sciences Centre** · enrollment: 5 (estimated)

## Conditions studied

- Alzheimer s Disease
- Alzheimer Dementia
- Alzheimer Dementia (AD)
- Alzheimer Disease
- Mild Cognitive Disorder
- Neurocognitive Disorders, Mild
- Neurocognitive Disorder

## Interventions

- **OTHER:** Fisetin

## Key facts

- **NCT ID:** NCT07279714
- **Lead sponsor:** Sunnybrook Health Sciences Centre
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-01-27
- **Primary completion:** 2026-11
- **Final completion:** 2026-11
- **Target enrollment:** 5 (ESTIMATED)
- **Last updated:** 2026-04-13

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07279714

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07279714, "Fisetin in Mild Alzheimer's Disease". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT07279714. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*